福美坦治疗期间出现严重免疫性血小板减少症。
Severe immune thrombocytopenia during formestane treatment.
作者信息
Español I, Muñíz-Díaz E, Alonso M C, Pujol-Moix N
出版信息
Haematologica. 1998 Oct;83(10):953-4.
PMID:9830809
Abstract
Formestane is a new aromatase inhibitor used as second-line endocrine treatment for postmenopausal women with advanced breast cancer. The most frequent side effects are local reactions. Here we report the development of immune thrombocytopenia coinciding with administration of this drug.
摘要
福美坦是一种新型芳香化酶抑制剂，用作晚期乳腺癌绝经后女性的二线内分泌治疗药物。最常见的副作用是局部反应。在此，我们报告了与该药物给药同时发生的免疫性血小板减少症。
Zotero 插件